BIODESIX INC
美股 BDSX正常交易Biodesix, Inc. ("Biodesix", "we", "us", "our" or the "Company") is a leading diagnostic solutions company. Our mission at Biodesix is to transform patient care and improve outcomes through personalized diagnostics that are timely, accessible, and address immediate clinical needs. We envision a world where patient disease is conquered through the guidance of personalized diagnostics. We derive our revenue from two sources: (i) Biodesix Lung Diagnostic Testing (Lung Diagnostic Testing), providing lung diagnostic testing services for healthcare providers associated with our five blood-based tests, and (ii) Biodesix Development Services (Development Services), providing diagnostic testing services and consulting to biopharmaceutical, life sciences, and diagnostic companies.
行情来源:新浪财经
- 行业
- 诊断与研究
- 交易所/板块
- 纳斯达克
- CIK(SEC)
- 0001439725
- 国家/注册地
- 美国
- 上市日期
- 2020-10-28
- 事件总数
- 253
- 最新事件
- 2026-08-05
公司档案来源:SEC EDGAR(申报文件/公司信息)· 新浪财经(行情/中文名)